It was obvious that HCC patients with higher mRNA levels of YTHDF1, YTHDF2, IGF2BP1, IGF2BP2, IGF2BP3, HNRNPC, NKAP displayed shorter overall survival (OS) time (Figure 6). Here, IGF2BP1 is linked to hepatocellular carcinoma.